kapi

KAPI WEEKLY BRIEF: 18TH – 22ND JAN. 2021

Executive Summary The Kenya Association of Pharmaceutical Industry (KAPI) is a membership organization, established in the late 1960s, representing biopharmaceutical manufacturers (or their local representatives) that through research invent and develop medicines and technologies (e.g., Biopharmaceuticals, Vaccine Healthcare, Medical devices, Diagnostics) that significantly improve people’s lives. KAPI represents the industry voice and promotes efficiency in […]

KAPI WEEKLY BRIEF: 18TH – 22ND JAN. 2021 Read More »

KAPI WEEKLY BRIEF: 11TH – 15TH JANUARY 2021

Executive Summary The Kenya Association of Pharmaceutical Industry (KAPI) is a membership organization, established in the late 1960s, representing biopharmaceutical manufacturers (or their local representatives) that through research invent and develop medicines and technologies (e.g., Biopharmaceuticals, Vaccine Healthcare, Medical devices, Diagnostics) that significantly improve people’s lives. KAPI represents the industry voice and promotes efficiency in

KAPI WEEKLY BRIEF: 11TH – 15TH JANUARY 2021 Read More »

KAPI Leadership Pays a Courtesy visit to the PS, Ministry of Health

On Tuesday 26th January 2021 the Kenya Association of Pharmaceutical Industry (KAPI) executive board led by the Chairperson, Willy Soriney paid a courtesy visit to the Principal Secretary, Ministry of Health Madam Susan Mochache. This was part of the associations’ stakeholder engagement mechanisms aimed at fostering collaborative spirit for the advancement of the health agenda for

KAPI Leadership Pays a Courtesy visit to the PS, Ministry of Health Read More »

Biopharmaceutical Companies Take Lead in COVID-19 Response in Kenya

As a membership organization driven by tenets of social responsibility and commitment to public health, in the wake of COVID-19 it is in our purview to drive a common agenda to flatten the curve of transmission, build concerted efforts to ensure uninterrupted supply of medicines, diagnostics and healthcare technologies. Additionally, our member companies have been

Biopharmaceutical Companies Take Lead in COVID-19 Response in Kenya Read More »

KAPI confirms commitment to affordably deliver Non-Communicable Diseases medicines

The Kenya Association of Pharmaceutical Industry (KAPI) has expressed its commitment to continue facilitating a progressive reduction in the cost of Non communicable diseases (NCDs) medicines locally. In a swift response to a public call by President Uhuru Kenyatta to international pharmaceutical firms, to reduce the cost of NCD medicines, KAPI, has confirmed ongoing efforts

KAPI confirms commitment to affordably deliver Non-Communicable Diseases medicines Read More »

KENYA FEATURES PROMINENTLY IN GLOBAL PHARMACEUTICAL INDUSTRY REPORT

…As the global pharmaceutical industry advocates for even greater collaboration as critical to future global health progress The International Federation of Pharmaceutical Manufacturers & Associations IFPMA has launched a report detailing milestones achieved in the health sector worldwide over the last 50 years. The report launched today features Kenya as a key player in the

KENYA FEATURES PROMINENTLY IN GLOBAL PHARMACEUTICAL INDUSTRY REPORT Read More »